Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ · Healthcare
Insight Molecular Diagnostics Inc. Balance Sheet 2020–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total Assets | 25.8M | 35.1M | 74.9M | 100.1M | 159.6M | 55.4M |
| Cash & Equivalents | 11.6M | 8.6M | 9.4M | 20.0M | 32.9M | 7.1M |
| Liabilities | ||||||
| Total Liabilities | 57.2M | 47.4M | 49.3M | 60.5M | 94.3M | 21.9M |
| Long-Term Debt | — | — | — | — | — | — |
| Equity | ||||||
| Shareholders' Equity | -31.5M | -12.3M | 20.5M | 34.3M | 65.2M | 33.5M |
Insight Molecular Diagnostics Inc. Balance Sheet — FAQ
Insight Molecular Diagnostics Inc. (IMDX) balance sheet over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see IMDX's balance sheet history?
The chart and table above show Insight Molecular Diagnostics Inc.'s balance sheet by year and by quarter, including the growth rate.